Oligodendrocytes and Schwann cells not only form myelin in the central and peripheral nervous system, but also provide metabolic and trophic support to the axons they ensheathe. Acetyl-CoA is potentially a key molecule in Schwann cells and oligodendrocytes because it is at the crossroads of cellular lipid biosynthesis and energy generation. The main route for acetyl-CoA production is the oxidation of pyruvate by the pyruvate dehydrogenase complex (PDC). PDC deficiency in humans results in neurodegeneration and developmental impairments in both white and gray mat- 
| I N T R O D U C T I O N
Oligodendrocytes (OLs) and Schwann cells (SCs) are myelinating glial cells and insulate axons in central nervous system (CNS) and peripheral nervous system (PNS), respectively. However, their functions go beyond the electrical insulation and include, among others, mechanical protection and trophic support of axons (Monk, Feltri, & Taveggia, 2015; Nave, 2010) . As a consequence, a great variety of myelin and axonal pathologies arises when myelinating cells are impaired, such as in multiple sclerosis (Lassmann, 2014) , leukodystrophies and peripheral neuropathies (Berger, Niemann, & Suter, 2006; Nave, 2010) . Nonetheless, the neuroprotective actions of SCs and OLs seem to be independent from the presence of myelin. Indeed, OLs and SCs are essential for neuronal survival and protection of axons (Beirowski et al., 2014; Funfschilling et al., 2012; Lee et al., 2012; Viader et al., 2011; Yin et al., 2016) . Also, studies in the last decades have shown that myelin loss is not directly linked to axonal damage, since one can occur independently of the other in different animal models, such as Mbp mutant mice (shiverer) (Rosenbluth, 1980) , Plp-null mice (Griffiths et al., 1998 ), Long-Evans Shaker rat (Smith, Cooksey, & Duncan, 2013) , and Cnp-null mice (Lappe-Siefke et al., 2003) .
Brain neurons require large amount of energy and consume up to 20% of the glucose in the blood and a similar amount of oxygen. The vast majority (estimated at 89%) of the energy is needed to produce action potentials and maintain synaptic communication (Attwell & Laughlin, 2001) , processes that usually take place away from the neuronal cell body. Because most of molecules are synthesized in the neuronal soma, it is likely that some support to axons derives from adjacent cells (Hirrlinger & Nave, 2014; Nave, 2010) . Thus, it has been proposed that one way myelinating glial cells protect neurons is to provide lactate and other metabolites to axons (Lee et al., 2012) . However, this unforeseen role of myelinating glial cells is not completely understood. Moreover, it is not known if these cells developed unique metabolic adaptations to carry out this function.
Acetyl-CoA is potentially a key molecule in OLs and SCs because it is at the crossroads of lipid metabolism (serving as a substrate for lipid biosynthesis) and energetics (conveying the carbons from glucose to be oxidized in the tricarboxylic acid cycle). Pyruvate generated from glucose oxidation is converted to acetyl-CoA by the mitochondrial pyruvate dehydrogenase complex (PDC). Acetyl-CoA can then be mobilized to the tricarboxylic acid (TCA) cycle and follow oxidative steps that culminate with ATP production through the electron transport chain (Rich, 2003) .
Interestingly, unlike in other tissues, a high proportion (70%) of PDC in the brain is maintained in its dephosphorylated (active) form (Halim et al., 2010; Siess, Wittmann, & Wieland, 1971) . Consistently, the human pathology associated with PDC deficiency is primarily manifested as neurological dysfunctions caused by neurodegeneration and developmental impairments in both white and gray matter structures.
This phenotype is recapitulated in conditional knockout mice that express a Pdha1 gene floxed around exon 8 and Cre recombinase under control of adenovirus EIIa promoter (inducing mosaic recombination in many embryonic tissues before implantation) (Johnson et al., 2001 ; Pliss et al., 2013; Pliss, Pentney, Johnson, & Patel, 2004) or Nes promoter (inducing recombination in both neuron and glial progenitors) (Johnson et al., 2001; Pliss et al., 2004 Pliss et al., , 2013 . Pdha1 is an X-linked gene that codes for the alpha (a) subunit of the first component of the pyruvate dehydrogenase complex (PDHa). PDH catalyzes the ratelimiting step of the PDC. The integrity of Pdha1 exon 8 is fundamental for its function, since deletion reduces the activity of the PDC by 99% in embryonic stem cells (Johnson et al., 2001) . However, the relative contributions of glia to the pathological findings in PDC deficiency are still not well characterized.
Thus, we deleted the Pdha1 gene in myelinating glial cells to understand the importance of PDC activity and acetyl-CoA production from pyruvate. We generated mice expressing a floxed Pdha1 gene in conjunction with Cre recombinase under the promoter of either Cnp (expressed in both OLs and SCs), P0 (expressed only by SCs), or NG2 (expressed in oligodendrocyte precursor cells). We report that myelinating glial cells are unlikely to be the main contributors in the pathology associated with pyruvate dehydrogenase complex deficiency.
| MATERIALS A ND METHODS

| Animal models
All experiments involving animals followed experimental protocols approved by the Roswell Park Cancer Institute and University at Buffalo. Pdha1 floxed, Mpz-Cre transgenic (P0-Cre), Cspg4-Cre ER transgenic (NG2-Cre ER ) and Cnp knock-in (Cnp Cre/1 ) mice were described previously (Feltri et al., 1999; Johnson et al., 2001; Lappe-Siefke et al., 2003; Zhu et al., 2011) 
| Morphological assessments
Mutant and control littermates were euthanized at the indicated ages, and sciatic nerves, spinal cord, and optic nerves were dissected. Nerves were prepared as in Quattrini et al. (1996) . Briefly, tissues were fixed in 2% buffered glutaraldehyde and post fixed in 1% osmium tetroxide.
After alcohol dehydration, the samples were embedded in Epon. Transverse sections (0.5-1 nm thick) were stained with toluidine blue and examined by light microscopy. Ultrathin sections were stained with uranile acetate and lead citrate and examined by electron microscopy.
For G-ratio analysis of sciatic nerves (axon diameter/fiber diameter), four images per semithin section were acquired at the 100x objective.
Axon and fiber diameters were quantified using the Leica QWin software (Leica Microsystem). For G-ratio analysis of the optic nerve, the myelin thickness and axon diameter of at least 50 fibers per animal were quantified in electron micrographs using ImageJ (imagej.nih.gov/ ij). Myelinated fibers were also quantified using ImageJ (imagej.nih.gov/ ij). Data were analyzed using GraphPad Prism 6.01. Images were blindly evaluated during analysis.
| Polymerase chain reaction
Genotyping of mutant mice was performed by PCR on tail genomic DNA, as described previously (Feltri et al., 1999; Johnson et al., 2001; Lappe-Siefke et al., 2003; Zhu et al., 2011) . The region surrounding exons 7 and 8 of Pdha1 alleles was amplified with primers Pdha1S1 5 0 AGCAGCCAGCACGGACTACT 3 0 and Pdha1AS2 5 0 GCAGCCAAACA-GATTACACC 3 0 . The sizes of amplification products using these primers are about 700 bp for wt allele, 800 bp for floxed allele and 400 bp for recombined allele.
| Behavioral analyses
Rotarod analyses were performed as described (Poitelon et al., 2012 
| Immunohistochemistry
Primary Schwann cells were prepared and maintained as described (Feltri, Scherer, Wrabetz, Kamholz, & Shy, 1992) 
| Western blot
Spinal cord and sciatic nerves were dissected and the epineurium was removed from sciatic nerves. Tissues were frozen in liquid nitrogen, pulverized, resuspended in lysis buffer and processed by SDS-PAGE as described (Poitelon et al., 2015) . Blots were then blocked with 5% BSA in 13 PBS, 0.05% Tween-20 and incubated overnight with the appropriate antibody: anti-PDH 1/1000 (Pliss et al., 2004) , and Sigma antiCalnexin 1/3000 (C4731). Membranes were then rinsed in 13 PBS and incubated for 1 h with secondary antibodies. Blots were developed using Odyssey CLx infrared imaging system (Li-Cor). Western blots were quantified using Image J software (imagej.nih.gov/ij). Each experiment was performed at least two times. All uncropped blots are presented in Supporting Information Figure 6 .
FIGU RE 2. 
| Data availability
The authors declare that the data supporting the findings of this study are available within the article and its Supporting Information files. All original data are available from the corresponding author upon request. ). Cnp is expressed in differentiating myelinating glia, as early as E13 in spinal cord and E14.5 in sciatic nerve, and is maintained at high levels during myelin synthesis, thus allowing the recombination of Pdha1 both in OLs and SCs (Genoud et al., 2002; Grigoryan et al., 2013; Lappe-Siefke et al., 2003; Reynolds & Wilkin, 1988) . PCR analyses of Pdha1 showed that Cnp Cre/1 recombined the Pdha1 floxed allele in white matter structures of the nervous system (Figure 1c, d ). Yet, the reduction of PDHa, encoded by Pdha1, could only be observed at the protein level in sciatic nerves, probably because their cellular composition is enriched in myelinating glial cells as opposed to spinal cord samples (Figure 1e ). Another potential explanation is that residual PDH protein may still be present in OLs at 30 days of age, as it has been suggested for other mitochondrial proteins in OLs (Funfschilling et al., 2012) . We also observed a reduction of the beta subunit of PDH, encoded by Pdhb (Figure 1e ). The reduced level of PDHb is due the mutual stabilizing interaction between PDHa and PDHb (Johnson et al., 2001) . 
Cnp
Cre/1 mice.
| Expression of Pdha1 in OLs is dispensable for the long-term maintenance of CNS myelination
Considering that myelin is not affected by Pdha1 conditional knock-out in 1-month old animals, we then sought to answer whether myelin structure is maintained long-term. Myelin structure in optic nerves was ). This could be explained by a rapid local metabolization of lactate in the CNS (Funfschilling et al., 2012) .
In addition to our Cnp Cre/1 model targeting all myelinating glia cells, we also generated Pdha1
; NG2-Cre ER mice, which allow postnatal recombination of Pdha1 specifically in OL precursor cells upon tamoxifen injection (Zhu et al., 2011) . As demonstrated by PCR, recombination was generated in the desired tissue (Figure 4a ), resulting in a marked reduction of Pdha1 mRNA levels in optic nerves of NG2-Cre increased lactate levels and diminished ATP/ADP ratio in sciatic nerves at 10 months (Table 1) .
Taken together, these data indicate that, even though ablation of Pdha1 does alter SCs metabolism (reducing available ATP and increasing the conversion of pyruvate to lactate) in both conditional null animals, this is not enough to cause impairment of myelin wrapping or myelin stability. However, it is possible that these metabolic imbalances in SCs caused nonautonomous effects on axons only in the Cnp
Cre/1 ; Pdha1 floxed mice.
| DISCUSSION
Acetyl-CoA is a key metabolic product of major catabolic pathways including the oxidation of pyruvate and b-oxidation of fatty acids. In catabolic normoxic conditions, acetyl-CoA is generated in the mitochondrial matrix where it is essential to fuel oxidative metabolism [for review see (Pietrocola, Galluzzi, Bravo-San Pedro, Madeo, & Kroemer, 2015) ]. Here we show for the first time that the production of acetyl-CoA from pyruvate is not required for myelin maintenance in vivo. Pdha1 deletion results in a deficiency of pyruvate dehydrogenase complex, the sole enzyme allowing the conversion of pyruvate to acetyl-CoA (Johnson et al., 2001) . As a consequence, we observed a significant reduction of ATP/ADP ratio ( 30%) followed by an increase of lactate level ( 50%) in peripheral nerves of animals ablated for Pdha1 in SCs. Nonetheless, these metabolic alterations did not affect the capacity of SCs to produce and maintain myelin. Since integrity of both peripheral and central nervous system structures were pre- through monocarboxylate transporters (Funfschilling et al., 2012; Lee et al., 2012; Volkenhoff et al., 2015) and utilizing cytosolic acetyl-CoA to promote lipid synthesis for myelin production. In this sense, our results corroborate the hypothesis that both OLs and SCs are mainly glycolytic, and impairing the production of acetyl-CoA from pyruvate does not affect myelin maintenance or cell survival.
On the other hand, there is evidence that oxidative metabolism is stimulated during late stages of differentiation and active myelination in SCs, possibly to promote generation of citrate, which is then exported from mitochondria to serve as carbon source for lipid synthesis (Pooya et al., 2014) . Moreover, previous observations indicate that aerobic glycolysis can suffice for the basic functions of OLs but not SCs (Funfschilling et al., 2012) . We showed that in animals ablated for PDC in SCs, lactate levels are increased and ATP/ADP ratio is reduced in sciatic nerves. Previous data have shown that lactate is efficiently metabolized by myelinated axons (Funfschilling et al., 2012) ; thus, it is unlikely that lactate would accumulate in axons without being metabolized. Therefore, the lactate accumulation and ATP/ADP ratio reduction are probably reflective of the metabolic changes in SCs. This supports the hypothesis that, in adult animals, SCs use aerobic respiration and ablation of PDC induces a metabolic shift towards a more glycolytic phenotype. Thus, while mitochondrial function and aerobic respiration are necessary for SC development and myelination (Funfschilling et al., 2012; Viader et al., 2011) , our results indicate that pyruvate-derived acetyl-CoA is dispensable for timely and adequate myelin formation and myelin maintenance in SCs. It remains unclear if myelinating glia metabolism is robust enough to cope with a reduction of acetyl-CoA levels or if they are able to compensate for PDC absence by generating acetyl-CoA from sources other than pyruvate.
In addition to glucose, OLs can efficiently uptake and metabolize acetate (Amaral et al., 2016; Marin-Valencia et al., 2012) and ketone bodies (Edmond, Robbins, Bergstrom, Cole, & de Vellis, 1987) , which might be particularly important during early postnatal development, since milk is the main nutrient source (Patel & Owen, 1977) . Additionally, catabolism of several amino acids can generate acetyl-CoA without passing through the PDC reaction in the mitochondria. Another wellstudied example is N-Acetylaspartate (NAA), a metabolite produced exclusively by neurons that reaches astonishing concentrations (up to 10 mM) in the CNS and has been proposed to be transferred to OLs to further support myelination. NAA can be taken up by OLs and be hydrolyzed by aspartoacylase to generate acetate (Moffett et al., 2011) , which is then used to synthesize fatty acids that are incorporated into myelin (Moffett, Ross, Arun, Madhavarao, & Namboodiri, 2007) . However, the individual contributions of these different substrates to OLs and SCs metabolism in vivo remains to be defined. caused by PDC ablation lead to production of compounds that are detrimental for axonal maintenance. For example, acidification of glial cells, which can be caused by accumulation of lactate, has already been linked to neuronal death through excitotoxicity (Beppu et al., 2014) . In addition, CNP loss of function can be an important disease modifier in PDC deficiency. A role for CNP in the establishment of the first OLaxon contact as well as the organization of cytoplasmic channels in myelin has also been proposed (Edgar et al., 2009; Snaidero et al., 2017) . As a consequence, metabolic coupling between axons and myelin forming glia could be perturbed in CNP haploinsufficient animals.
Therefore, the axonopathy of Pdha1 f/Y ; Cnp Cre/1 mice could be due to decreased production of metabolites from TCA products associated to impaired capacity of OLs and SCs to transport these metabolites to
axons.
An alternative explanation for the axonopathy would be that Cnp expression is not exclusive to myelinating glial cells. Indeed, it has been shown that Cnp is expressed prenatally by motor neurons and by retinal ganglion cells of lower vertebrates (Ballestero, Dybowski, Levy, Agranoff, & Uhler, 1999; Genoud et al., 2002; Heath & Hindman, 1986) , and radial glial cells and other progenitors can transiently express Cnp at low levels (Tognatta et al., 2017) . Overall, the use of
Cnp
Cre/1 animals to study long-term metabolism of myelinating glial cells should be carefully considered.
In conclusion, efficient Schwann cell-specific and oligodendrocytespecific ablation of PDC has no detectable effect on the development and maintenance of myelin. Thus, OLs are likely to be a minor contributor in the pathophysiology of PDC deficiency. Our findings corroborate the growing body of evidence suggesting the metabolism of myelinating glial cells is highly adaptable, but primarily relies on aerobic glycolysis. It is now essential to better characterize the metabolic adaptations that allow the massive and rapid membrane expansion during myelinogenesis and the long-term support of the highly energydemanding axons. Deciphering some points of this interaction could reveal new physiological targets for drug development and lead to advances in medical methodologies aiming to restore nerve function or prevent the axon damage in many demyelinating and neurodegenerative diseases.
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